Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
| # | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|---|---|---|---|---|---|---|
| 1 | M1.ON.17.4869 | 109739 |
Oncology
|
Benign Bone Tumors |
M 1
|
D
|
| 2 | M1.MK.17.4722 | 108536 |
MSK
|
Scleroderma |
M 1
|
D
|
| 3 | M1.EC.17.4707 | 108430 |
Endocrine
|
Sheehan Syndrome |
M 1
|
D
|
| 4 | M1.PY.17.4873 | 109988 |
Psychiatry
|
Methylphenidate (Ritalin) |
M 1
|
D
|
| 5 | M1.RL.17.4799 | 109341 |
Renal
|
Horseshoe Kidney |
M 1
|
D
|
| 6 | M1.BC.17.4708 | 108464 |
Biochemistry
|
Transcription |
M 1
|
D
|
| 7 | M1.BC.17.4766 | 109051 |
Biochemistry
|
Electron Transport Chain |
M 1
|
D
|
| 8 | M1.BC.17.4774 | 109101 |
Biochemistry
|
Citric Acid Cycle |
M 1
|
D
|
| 9 | M1.EB.17.4750 | 108776 |
Embryology
|
Umbilical Cord and Remnants |
M 1
|
D
|
| 10 | M1.EB.17.4817 | 109390 |
Embryology
|
Tongue and Thyroid Development |
M 1
|
D
|
| 11 | M1.EB.17.4767 | 109054 |
Embryology
|
Fetal Circulation and Erythropoiesis |
M 1
|
D
|
| 12 | M1.MC.17.4723 | 108525 |
Microbiology
|
Pseudomonas aeruginosa |
M 1
|
D
|
| 13 | M1.MC.17.4723 | 108540 |
Microbiology
|
Macrolides |
M 1
|
D
|
| 14 | M1.CV.17.4817 | 109377 |
Cardiovascular
|
Sites of Action for Cardiac Drugs |
M 1
|
D
|
| 15 | M1.CV.17.4867 | 109637 |
Cardiovascular
|
Myocardial Action Potential |
M 1
|
D
|
| 16 | M1.NE.14.77 | 106891 |
Neurology
|
Diseases of Myelination |
M 2
|
D
|
| 17 | M1.PL.13.250 | 100766 |
Respiratory
|
Pulmonary Thromboembolism |
M 2
|
D
|
| 18 | M1.CV.17.4867 | 109648 |
Cardiovascular
|
Patent Ductus Arteriosus |
M 2
|
D
|
| 19 | M1.EC.17.4699 | 108293 |
Endocrine
|
Sheehan Syndrome |
M 2
|
D
|
| 20 | M1.MC.17.4707 | 108442 |
Microbiology
|
Cutaneous and Subcutaneous Mycoses |
M 2
|
D
|
| 21 | M1.ON.16.4699 | 108389 |
Oncology
|
Thyroid Cancer |
M 2
|
D
|
| 22 | M1.AN.17.4740 | 108651 |
MSK
|
Brachial Plexus |
M 2
|
D
|
| 23 | M1.PY.17.4726 | 108557 |
Psychiatry
|
Panic Disorder |
M 2
|
D
|
| 24 | M1.EB.17.4753 | 108834 |
Embryology
|
Fetal Circulation and Erythropoiesis |
M 3
|
D
|
| 25 | M1.BC.17.4775 | 109104 |
Biochemistry
|
Pyruvate Dehydrogenase Complex |
M 3
|
D
|
| 26 | M1.CV.17.4754 | 108867 |
Cardiovascular
|
Cardiac Tumors |
M 4
|
D
|
| 27 | M1.MC.17.4798 | 109260 |
Microbiology
|
Flukes (Trematodes) |
M 3
|
D
|
| 28 | M1.MC.17.4754 | 108866 |
Microbiology
|
Neisseria gonorrhoeae |
M 3
|
D
|
| 29 | M1.BC.17.4799 | 109298 |
Biochemistry
|
Amino Acids |
M 3
|
D
|
| 30 | M1.NE.17.4719 | 108509 |
Neurology
|
Visual Pathway |
M 3
|
D
|
| 31 | M1.EC.17.4869 | 109863 |
Endocrine
|
Pituitary Apoplexy |
M 3
|
D
|
| 32 | M1.EC.17.4868 | 109708 |
Endocrine
|
Prolactin |
M 3
|
D
|
| 33 | M1.GI.17.4768 | 109055 |
Gastrointestinal
|
Hepatitis |
M 3
|
D
|
| 34 | M1.PY.17.4707 | 108438 |
Psychiatry
|
Atypical Antidepressants |
M 3
|
D
|
| 35 | M1.PY.17.4868 | 109809 |
Psychiatry
|
Tourette Syndrome |
M 3
|
D
|
| 36 | M1.RP.17.4868 | 109595 |
Reproductive
|
Antiandrogens |
M 3
|
D
|
| 37 | M1.PY.17.4755 | 108917 |
Psychiatry
|
Other Pervasive Developmental Disorders |
M 2
|
D
|
| 38 | M1.PY.17.4699 | 108377 |
Psychiatry
|
Other Pervasive Developmental Disorders |
M 2
|
D
|
| 39 | M1.NE.17.4873 | 109978 |
Neurology
|
Neural Tube Defects |
M 2
|
D
|
| 40 | M1.ON.17.4752 | 108766 |
Oncology
|
Testicular Tumors |
M 2
|
D
|
| 41 | M1.ON.17.4722 | 108544 |
Oncology
|
Metastasis |
M 2
|
D
|
| 42 | M1.GI.17.4800 | 109281 |
Gastrointestinal
|
Alcoholic Liver Disease |
M 2
|
D
|
| 43 | M1.GI.17.4753 | 108848 |
Gastrointestinal
|
Angiodysplasia |
M 2
|
D
|
| 44 | M1.MK.17.4722 | 108545 |
MSK
|
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
M 2
|
D
|
| 45 | M1.MK.17.4722 | 108534 |
MSK
|
Paget Disease of Bone |
M 2
|
D
|
| 46 | M1.ON.17.4798 | 109235 |
Oncology
|
Esophageal Cancer |
M 2
|
D
|
| 47 | M1.NE.17.4799 | 109325 |
Neurology
|
Brainstem |
M 2
|
D
|
| 48 | M1.NE.17.4695 | 108019 |
Neurology
|
Wernicke-Korsakoff Syndrome |
M 2
|
D
|
| 49 | M1.PH.17.4699 | 108317 |
Pharmacology
|
Drug Excretion |
M 3
|
D
|
| 50 | M1.PH.17.4868 | 109705 |
Pharmacology
|
Autonomic Pathways |
M 3
|
D
|
| 51 | M1.BC.17.4723 | 108552 |
Biochemistry
|
Ethanol Metabolism |
M 3
|
D
|
| 52 | M1.MC.14.31 | 101152 |
Microbiology
|
Helicobacter pylori |
M 3
|
D
|
| 53 | M1.PL.17.4754 | 108712 |
Respiratory
|
Fat Embolus Syndrome |
M 2
|
D
|
| 54 | M1.HE.17.4873 | 109974 |
Hematology
|
Von Willebrand Disease |
M 2
|
D
|
| 55 | M1.BC.17.4766 | 109046 |
Biochemistry
|
Karyotyping |
M 2
|
D
|
| 56 | M1.MC.17.4754 | 108960 |
Microbiology
|
Rubella Virus |
M 2
|
D
|
| 57 | M1.MC.17.4754 | 108953 |
Microbiology
|
Prions |
M 2
|
D
|
| 58 | M1.MC.17.4725 | 108556 |
Microbiology
|
Tapeworms (Cestodes) |
M 2
|
D
|
| 59 | M1.MC.17.4707 | 108433 |
Microbiology
|
Special Culture Requirements |
M 2
|
D
|
| 60 | M1.GI.13.76 | 101133 |
Gastrointestinal
|
Peptic Ulcer Disease |
M 2
|
D
|
| 61 | M1.EC.13.57 | 100573 |
Endocrine
|
Hyperaldosteronism / Conn Syndrome |
M 2
|
D
|
| 62 | M1.MC.17.4725 | 108554 |
Microbiology
|
Metronidazole |
M 1
|
D
|
| 63 | M1.MC.17.4727 | 108558 |
Microbiology
|
Rubeola (Measles) |
M 1
|
D
|
| 64 | M1.MC.17.4798 | 109224 |
Microbiology
|
Viral Envelopes |
M 1
|
D
|
| 65 | M1.MC.17.4695 | 108056 |
Microbiology
|
Special Culture Requirements |
M 1
|
D
|
| 66 | M1.EB.17.4867 | 109636 |
Embryology
|
Changes in the Elderly |
M 1
|
D
|
| 67 | M1.EB.17.4869 | 109718 |
Embryology
|
Placental Components |
M 1
|
D
|
| 68 | M1.BC.17.4753 | 108851 |
Biochemistry
|
Lipoprotein Disorders |
M 1
|
D
|
| 69 | M1.BC.17.4754 | 108937 |
Biochemistry
|
Amino Acids |
M 1
|
D
|
| 70 | M1.RL.17.0 | 109761 |
Renal
|
Relative Concentrations along Proximal Tubule |
M 1
|
D
|
| 71 | M1.RL.17.4872 | 109882 |
Renal
|
Relative Concentrations along Proximal Tubule |
M 1
|
D
|
| 72 | M1.NE.17.4870 | 109827 |
Neurology
|
Visual Pathway |
M 1
|
D
|
| 73 | M1.NE.17.4869 | 109768 |
Neurology
|
Wernicke-Korsakoff Syndrome |
M 1
|
D
|
| 74 | M1.PY.17.4799 | 109348 |
Psychiatry
|
Monoamine Oxidase (MAO) Inhibitors |
M 1
|
D
|
| 75 | M1.NE.17.4827 | 109431 |
Neurology
|
Wernicke-Korsakoff Syndrome |
M 1
|
D
|
| 76 | M1.PL.17.4695 | 107961 |
Respiratory
|
Dead Spaces and Ventilation Rates |
M 1
|
D
|
| 77 | M1.PL.17.4869 | 109792 |
Respiratory
|
Dead Spaces and Ventilation Rates |
M 1
|
D
|
| 78 | M1.EC.17.4871 | 109850 |
Endocrine
|
Waterhouse-Friderichsen Syndrome |
M 1
|
D
|
| 79 | M1.GI.17.4868 | 109706 |
Gastrointestinal
|
Pancreatic Enzymes |
M 1
|
D
|
| 80 | M1.ON.17.4717 | 108500 |
Oncology
|
Non-Hodgkin Lymphoma |
M 1
|
D
|
| 81 | M1.ON.17.4874 | 109998 |
Oncology
|
Tumor Markers |
M 1
|
D
|
| 82 | M1.MK.17.4740 | 108654 |
MSK
|
Polymyositis / Dermatomyositis |
M 1
|
D
|
| 83 | M1.NE.17.4798 | 109178 |
Neurology
|
Cavernous Sinuses |
M 1
|
D
|
| 84 | M1.MC.13.10 | 101469 |
Microbiology
|
Parvovirus B19 |
M 1
|
D
|
| 85 | M1.MK.17.4754 | 108931 |
Dermatology
|
Staphylococcal Scalded Skin Syndrome (SSSS) |
M 1
|
D
|
| 86 | M1.MK.17.4768 | 109076 |
Dermatology
|
Bullous Pemphigoid |
M 1
|
D
|
| 87 | M1.MK.17.4722 | 108529 |
Dermatology
|
Vitiligo |
M 1
|
D
|
| 88 | M1.ON.17.4869 | 109748 |
Oncology
|
Parathyroid Adenoma |
M 1
|
D
|
| 89 | M1.ON.17.4751 | 108789 |
Oncology
|
Platinum Analogs |
M 1
|
D
|
| 90 | M1.ON.17.4747 | 108672 |
Oncology
|
Oncogenic Viruses |
M 1
|
D
|
| 91 | M1.ON.17.4754 | 108719 |
Oncology
|
Alkylating Agents |
M 1
|
D
|
| 92 | M1.EC.17.4750 | 108778 |
Endocrine
|
Parathyroid Hormone (PTH) |
M 1
|
D
|
| 93 | M1.EC.17.4798 | 109223 |
Endocrine
|
Signaling Pathways of Endocrine Hormones |
M 1
|
D
|
| 94 | M1.EC.17.4867 | 109602 |
Endocrine
|
Hypothalamic-Pituitary Axis |
M 1
|
D
|
| 95 | M1.PL.17.4768 | 109070 |
Respiratory
|
Oxygen Transport and Hemoglobin |
M 1
|
D
|
| 96 | M1.HE.17.4868 | 109814 |
Hematology
|
Bernard-Soulier Disease |
M 1
|
D
|
| 97 | M1.GI.17.4753 | 108849 |
Gastrointestinal
|
Gastric Secretion |
M 1
|
D
|
| 98 | M1.RL.17.4751 | 108791 |
Renal
|
Bladder / Urethra Anatomy |
M 1
|
D
|
| 99 | M1.RP.17.4754 | 108714 |
Reproductive
|
Mastitis |
M 1
|
D
|
| 100 | M1.RL.17.4830 | 109476 |
Renal
|
Glomerular Filtration Barrier |
M 1
|
D
|
| 101 | M1.RL.17.4868 | 109694 |
Renal
|
Glucose Clearance |
M 1
|
D
|
| 102 | M1.BC.17.4766 | 109045 |
Biochemistry
|
Microarrays |
M 1
|
D
|
| 103 | M1.BC.17.4755 | 108874 |
Biochemistry
|
Metabolism Overview |
M 1
|
D
|
| 104 | M1.BC.17.4798 | 109219 |
Biochemistry
|
Sorbitol |
M 1
|
D
|
| 105 | M1.BC.17.4798 | 109220 |
Biochemistry
|
Metabolism of Exercise and Starvation |
M 1
|
D
|
| 106 | M1.BC.17.4867 | 109597 |
Biochemistry
|
Galactose Metabolism |
M 1
|
D
|
| 107 | M1.BC.17.4878 | 109686 |
Biochemistry
|
Universal Electron Acceptors |
M 1
|
D
|
| 108 | M1.MC.17.4723 | 108528 |
Microbiology
|
Rifamycins |
M 1
|
D
|
| 109 | M1.GI.17.4798 | 109212 |
Gastrointestinal
|
Peutz-Jeghers Syndrome |
M 1
|
D
|
| 110 | M1.MC.17.4754 | 108829 |
Microbiology
|
Bacillus cereus |
M 1
|
D
|
| 111 | M1.MC.17.4867 | 109629 |
Microbiology
|
Bacterial Genetics |
M 1
|
D
|
| 112 | M1.MC.17.4868 | 109731 |
Microbiology
|
Coronavirus |
M 1
|
D
|
| 113 | M1.MC.17.4868 | 109732 |
Microbiology
|
Trimethoprim |
M 1
|
D
|
| 114 | M1.MC.17.4799 | 109295 |
Microbiology
|
Poliovirus |
M 1
|
D
|
| 115 | M1.IM.17.4707 | 108446 |
Immunology
|
Structure and Function of MHC |
M 1
|
D
|
| 116 | M1.MC.17.4725 | 108566 |
Microbiology
|
Influenza Viruses |
M 1
|
D
|
| 117 | M1.MC.17.4768 | 109057 |
Microbiology
|
Coronavirus |
M 1
|
D
|
| 118 | M1.MC.17.4768 | 109075 |
Microbiology
|
Protease Inhibitors |
M 1
|
D
|
| 119 | M1.MC.17.4796 | 109176 |
Microbiology
|
Klebsiella |
M 1
|
D
|
| 120 | M1.PH.17.4798 | 109231 |
Pharmacology
|
Efficacy vs. Potency |
M 1
|
D
|
| 121 | M1.MC.17.4800 | 109286 |
Microbiology
|
Leptospira interrogans |
M 2
|
D
|
| 122 | M1.MC.17.4800 | 109287 |
Microbiology
|
Haemophilus influenzae |
M 2
|
D
|
| 123 | M1.EB.17.4799 | 109317 |
Embryology
|
Lung Development |
M 2
|
D
|
| 124 | M1.MC.17.4695 | 108037 |
Microbiology
|
Vibrio parahaemolyticus / vulnificus |
M 2
|
D
|
| 125 | M1.MC.17.4799 | 109307 |
Microbiology
|
Rotavirus |
M 2
|
D
|
| 126 | M1.RL.17.4872 | 109899 |
Renal
|
Kidney Endocrine Functions |
M 2
|
D
|
| 127 | M1.IM.17.4754 | 108947 |
Immunology
|
Recombinant Cytokines |
M 3
|
D
|
| 128 | M1.MC.14.56 | 100859 |
Microbiology
|
Isoniazid |
M 3
|
D
|
| 129 | M1.GI.13.122 | 100638 |
Gastrointestinal
|
Gastritis |
M 4
|
D
|
| 130 | M1.EC.17.4726 | 108580 |
Endocrine
|
Neuroblastoma |
M 2
|
D
|
| 131 | M1.NE.17.4798 | 109225 |
Neurology
|
Seizures |
M 2
|
D
|
| 132 | M1.ON.17.4798 | 109262 |
Oncology
|
Cervical Cancer |
M 2
|
D
|
| 133 | M1.ON.17.4867 | 109646 |
Oncology
|
Hairy Cell Leukemia (HCL) |
M 2
|
D
|
| 134 | M1.MK.17.4722 | 108531 |
Dermatology
|
Seborrheic Keratosis |
M 2
|
D
|
| 135 | M1.ON.17.4707 | 108448 |
Oncology
|
Oncogenes |
M 2
|
D
|
| 136 | M1.GI.17.4768 | 109056 |
Gastrointestinal
|
Dubin-Johnson / Rotor Syndrome |
M 2
|
D
|
| 137 | M1.HE.17.4708 | 108477 |
Hematology
|
Bernard-Soulier Disease |
M 2
|
D
|
| 138 | M1.GI.17.4753 | 108847 |
Gastrointestinal
|
Alpha-1 Antitrypsin Deficiency |
M 2
|
D
|
| 139 | M1.ON.17.4751 | 108803 |
Oncology
|
Antitumor Antibiotics |
M 3
|
D
|
| 140 | M1.PL.17.4753 | 108898 |
Respiratory
|
Sinusitis |
M 3
|
D
|
| 141 | M1.NE.17.4870 | 109826 |
Neurology
|
Lewy Body Dementia |
M 3
|
D
|
| 142 | M1.ON.17.4753 | 108771 |
Oncology
|
Chronic Myeloid Leukemia (CML) |
M 3
|
D
|
| 143 | M1.NE.17.4753 | 108827 |
Neurology
|
Eye Anatomy |
M 3
|
D
|
| 144 | M1.MC.17.4822 | 109423 |
Microbiology
|
Hepatitis C Virus |
M 3
|
D
|
| 145 | M1.MC.17.4752 | 108768 |
Microbiology
|
Borrelia burgdorferi |
M 3
|
D
|
| 146 | M1.MC.17.4752 | 108809 |
Microbiology
|
Sulfonamides |
M 3
|
D
|
| 147 | M1.GI.17.4753 | 108844 |
Gastrointestinal
|
Octreotide |
M 3
|
D
|
| 148 | M1.NE.17.4873 | 109985 |
Neurology
|
Dantrolene |
M 3
|
D
|
| 149 | M1.HE.17.4868 | 109711 |
Hematology
|
Methemoglobinemia |
M 3
|
D
|
| 150 | M1.GI.17.4753 | 108845 |
Gastrointestinal
|
Metoclopramide |
M 2
|
D
|